Specifically, elevated Chit1 serum levels are associated with atherosclerosis, COPD, Alzheimer's disease and β-thalassemia, and is a biomarker for Gaucher's disease which affects lysosomal storage (17, 28–31). Here, CHIT1 is linked to early-onset autosomal dominant Alzheimer disease.